Published • loading... • Updated
What Alkermes (ALKS) Said on Its Q3 Earnings Call
Summary by MarketBeat
5 Articles
5 Articles
What Alkermes (ALKS) Said on Its Q3 Earnings Call
Alkermes (NASDAQ:ALKS) reported third-quarter 2026 results marked by 31% year-over-year growth in proprietary product sales, while management highlighted continued investment in its orexin development portfolio across sleep, neuropsychiatric and neurological disorders. Total revenue for the quarter
·Sioux Falls, United States
Read Full Article
What Ball (BALL) Said on Its Q3 Earnings Call
Ball (NYSE:BALL) reported higher global aluminum shipments and earnings for the third quarter of 2026, citing continued beverage-can demand across its operating regions and progress on new capacity investments. The company said it remains on track to deliver more than 10% comparable diluted earnings-per-share growth for the full year and plans to return approximately $800 […]
Coverage Details
Total News Sources5
Leaning Left1Leaning Right1Center1Last UpdatedBias Distribution34% Left, 33% Center, 33% Right
Bias Distribution
- 34% of the sources lean Left, 33% of the sources are Center, 33% of the sources lean Right
34% Left
L 34%
C 33%
R 33%
Factuality
To view factuality data please Upgrade to Premium
